CLINTRIALS RESEARCH INC (CIK: 0000870978) EDGAR, Information, Filings... CompaniesBIO.Com

CLINTRIALS RESEARCH INC

Mailing address
11000 WESTON PARKWAY, CARY, Delaware, 27513
Phone
9194622556
State location
North Carolina
State of incorporation
Delaware
Fiscal year end
December 31
SIC
8734 - (CF Office: Office of Trade & Services) SERVICES-TESTING LABORATORIES
Filings
N/A

CLINTRIALS RESEARCH INC (CIK: 0000870978) is an American company incorporated in the state of North Carolina. Head office is located at 11000 WESTON PARKWAY, CARY, North Carolina, 27513. Work in the industry 8734 - (CF Office: Office of Trade & Services) SERVICES-TESTING LABORATORIES. CLINTRIALS RESEARCH INC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by CLINTRIALS RESEARCH INC

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000950133-02-001111 ( Act) Size: KB	Mar-22-2002	005-45904 02582488
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000950133-01-500892 ( Act) Size: KB	May-03-2001	005-48381 1621459
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000950133-01-500891 ( Act) Size: KB	May-03-2001	005-48381 1621445
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0000950123-01-003190 ( Act) Size: KB	Apr-06-2001	000-22510 1597093
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950123-01-003093 ( Act) Size: KB	Apr-03-2001	005-48381 1594467
SC TO-T/A	Document	Amendment to Third party tender offer statement Acc-no: 0000950123-01-003087 ( Act) Size: KB	Apr-03-2001	005-48381 1594341
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950144-01-003729 ( Act) Size: KB	Mar-21-2001	005-48381 1573085
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950144-01-003728 ( Act) Size: KB	Mar-21-2001	005-48381 1573084
SC TO-T/A	Document	Amendment to Third party tender offer statement Acc-no: 0000950123-01-002445 ( Act) Size: KB	Mar-20-2001	005-48381 1572661
SC TO-T/A	Document	Amendment to Third party tender offer statement Acc-no: 0000950123-01-002393 ( Act) Size: KB	Mar-19-2001	005-48381 1571526
10-K405	Document	Acc-no: 0000950144-01-003340 ( Act) Size: KB	Mar-06-2001	000-22510 1562280
SC 14D9/A	Document	Amendment to Tender offer solicitation / recommendation statements filed under Rule 14d-9 Acc-no: 0000950144-01-003315 ( Act) Size: KB	Mar-05-2001	005-48381 1561561
SC TO-T	Document	Third party tender offer statement Acc-no: 0000950123-01-500149 ( Act) Size: KB	Mar-05-2001	005-48381 1561435
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950123-01-002017 ( Act) Size: KB	Mar-05-2001	005-48381 1561497
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950123-01-002016 ( Act) Size: KB	Mar-05-2001	005-48381 1561490
SC14D9C	Document	Written communication by the subject company relating to a third party tender offer Acc-no: 0000950144-01-003060 ( Act) Size: KB	Feb-23-2001	005-48381 1552539
SC TO-C	Document	Written communication relating to an issuer or third party tender offer Acc-no: 0000950123-01-001727 ( Act) Size: KB	Feb-23-2001	005-48381 1553159
SC TO-C	Document	Written communication relating to an issuer or third party tender offer Acc-no: 0000950123-01-001699 ( Act) Size: KB	Feb-23-2001	005-48381 1552544
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000354204-01-000435 ( Act) Size: KB	Feb-02-2001	005-48381 1522555
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950144-00-013557 ( Act) Size: KB	Nov-13-2000	000-22510 761778

Recent 20 filings. View all CLINTRIALS RESEARCH INC filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

CLINTRIALS RESEARCH INC overview
CLINTRIALS RESEARCH INC job
CLINTRIALS RESEARCH INC stock
CLINTRIALS RESEARCH INC ownership
CLINTRIALS RESEARCH INC CEO
CLINTRIALS RESEARCH INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.